HYBRID EVENT: You can participate in person at Rome, Itlay or Virtually from your home or work.

11th Edition of International Conference on

Neurology and Neurological Disorders

June 05-07, 2025 | Rome, Italy

Totipotent (or Omnipotent) Stem Cells

Totipotent (or Omnipotent) Stem Cells

Totipotent and omnipotent stem cells (TSCs) are special types of stem cells capable of differentiating into any cell type in the human body. They have the ability to divide and self-renew indefinitely, meaning they do not age and can be used for regenerative and clinical purposes. TSCs are the earliest form of stem cells in a developing embryo, and they play an essential role in the development of all body tissues and organs. They provide a unique opportunity for medical research and treatments in order to understand and treat a variety of diseases and disabilities. TSCs have an advantage over other stem cell types because they are undifferentiated--unspecialized--and can be used to generate cells from any tissue in the body. This means they can be used not only to create healthy replacement cells but also to differentiate into specific cell types, such as neurons, muscle cells, and cardiomyocytes (heart cells). TSCs have the potential to revolutionize regenerative medicine, as they can be used to regenerate damaged tissues and organs, including the heart, kidney, and pancreas. In addition to their regenerative potential, TSCs have also been used for gene therapy. They have been used to introduce beneficial genes in diseases like sickle cell anemia and muscular dystrophy, and for the repair of injured or defective organs. They are also used in stem cell banking, where healthy cells are frozen for future use in case of an illness or injury. TSCs have great potential for medical science, but they also come with ethical and safety concerns. One concern is that extracting TSCs from embryos may harm the developing fetus, while ethical considerations include the potential to create human embryos in petri dishes for medical research. Despite these, the immense potential of TSCs—from regenerative medicine to gene therapy— remains unquestioned. With the right research and development, this unique stem cell type may soon revolutionize the field of regenerative medicine and provide new treatments for a wide variety of diseases.

Committee Members
Speaker at Neurology and Neurological Disorders 2025 - Ken Ware

Ken Ware

NeuroPhysics Therapy Institute, Australia
Speaker at Neurology and Neurological Disorders 2025 - Robert B Slocum

Robert B Slocum

University of Kentucky HealthCare, United States
Speaker at Neurology and Neurological Disorders 2025 - Luiz Moutinho

Luiz Moutinho

University of Suffolk, United Kingdom
Neurology 2025 Speakers
Speaker at Neurology and Neurological Disorders 2025 - David Lominadze

David Lominadze

University of South Florida, United States
Speaker at Neurology and Neurological Disorders 2025 - Milton C R Medeiros

Milton C R Medeiros

Irmandade Santa Casa de Arapongas PR, Brazil
Speaker at Neurology and Neurological Disorders 2025 - Sang Hie Lee

Sang Hie Lee

University of South Florida, United States
Speaker at Neurology and Neurological Disorders 2025 - Sergei M Danilov

Sergei M Danilov

University of Illinois, United States

Submit your abstract Today

Watsapp